Skip to search formSkip to main contentSkip to account menu

brimonidine / brinzolamide Ophthalmic Suspension [Simbrinza]

National Institutes of Health

Related topics

Related topics

2 relations
Ophthalmic SuspensionSimbrinza

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Brinzolamide/Brimonidine Fixed Combination: Simplifying Glaucoma Treatment Regimens
IntroductionTo simplify the medical treatment of glaucoma for patients on multiple drops by introducing brinzolamide/brimonidine… 
Review
2015
Review
2015
Brinzolamide/Brimonidine: A Review of Its Use in Patients with Open-Angle Glaucoma or Ocular Hypertension
Brinzolamide 1 %/brimonidine 0.2 % ophthalmic suspension (Simbrinza®) is a fixed-combination of a carbonic anhydrase inhibitor… 
2014
2014
Simbrinza, INN - brinzolamnide/brimonidine tartrate
  • 2014
  • Corpus ID: 45324145
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)